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Commentary
Most would agree that providing comprehensive detail in scientific reporting is critical for the development of meaningful therapies and treatments for diseases. Such stellar practices 1) allow for reproduction of experiments to confirm results, 2) promote thorough analyses of data, and 3) foster the incremental advancement of valid approaches. Unfortunately, most would also agree we have far to go to reach this vital goal (Hackam and Redelmeier, 2006; Prinz et al., 2011; Baker et al., 2014) .
The clinical community has been held to a high standard (e.g., common data elements (CDE), see http://www.commondataelements.ninds.nih.gov; also see Moher et al, 2001 and updated in Moher 2010; and Anderson et al, 2005) . Slow to follow, there has been a momentum more recently toward improving the rigor applied to the conducting and reporting of basic science research. A major goal has been to demand improved experimental design, to apply more rigorous methodology standards, to use best practices throughout, and to apply a more thorough and precise reporting of not only positive results, but negative data as well. For example, in 2012, the National Institute of Neurological Disorders and Stroke (NINDS) brought together a group of 36 "academic researchers and educators, reviewers, journal editors and representatives from funding agencies, disease advocacy communities and the pharmaceutical industry" to formulate and publish a recommendation concerning the methodological reporting of animal studies (Landis et al., 2012) . This extensive and diverse team concluded that "sample-size estimation, whether and how animals were randomized, whether investigators were blind to the treatment, and the handling of data" were required, at a minimum. They encapsulated their recommendations as a "core set of reporting standards for rigorous study design", the goal of which was to improve the quality of research as well as the predictive capacity of such studies for clinical trials. For successful translation of scientific discoveries to clinical applications based on animal research, this type of effort must apply to all scientific documentation.
As one means of achieving this over-arching goal, there has been a call for professional societies to highlight the issue in their various scientific communities -a sort of "grass roots effort". Important projects that arose from such endeavors and serve as future models are the MIBBI (Taylor et al., 2008) and the MIAME (Brazma et al., 2001) .
One community that has wholly embraced this sweeping effort is related to nervous system injuries, i.e., traumatic brain injury (TBI), spinal cord injury (SCI), and peripheral nerve injury. For example, in 2003, a major project was adopted by the NINDS to replicate a number of leading SCI studies. Researchers from three leading SCI research centers performed replication experiments to validate results from original studies and showed an alarmingly high failure of confirmation. Explanations centered on inadequate reporting of details, such as issues related to animal use, injury methods, and reagents (Steward et al., 2012) . Given the movements described above and to build on these innovative and important efforts, Lemmon, Bixby and Visser report on a project they are leading, the Minimal Information About a Spinal Cord Injury project (MIASCI), designed to improve reporting standards for SCI animal studies. MIASCI began in 2011 with 35 scientists from the US and Japan (Growth Cones and Axon Regeneration: Entering The Age of Informatics.) One outcome of this effort was a table of > 250 data elements for consideration. The authors conclude that adherence to such a metadata report by SCI researchers could successfully address many of the recommendations called for by Landis et al. (2012) .
Insights from this effort led Lemmon and colleagues to a series of logical predictions: as detailed and transparent reporting improves, as it must, such a change will foster the adoption of more rigorous approaches to research in general, which will in turn lead to a drastically increased amount of SCI-related information being published each year. Such increased reports will bring a necessity for even greater data mining and better methods of bioinformatic analyses.
To address this "SCI data flood", Lemmon and colleagues are embarking upon an ontology engineering project called the RegenBase Ontology, which seeks "to develop an information framework and knowledge base to facilitate research about nervous system regeneration." According to their current report, the long-term goal of the RegenBase Ontology is to "connect information about SCI experiments to information about biological processes, molecular networks and high-throughput screening data to speed the identification and testing of novel therapeutics." As evidence of the usefulness of the system, as well as the need for an abundance of user input and feedback, the authors cite an example of discovery using this ontology. They have successfully queried the knowledge base for PKC inhibitors that promote regeneration of sensory neurons (see Figure 1 on page 15 in this issue), and obtained an answer to the specific question:
"What compounds that inhibit cPKC promote regeneration of proprioceptive DRG neurons in vivo?" Using a descriptive logic (DL) reasoning engine, they found that a compound called Gö6976 satisfied this query. This is just one of the exciting demonstrations of how this engine can rapidly provide useful data from an otherwise overwhelming and unmanageable set of factors.
As a testament to the importance of this work, the 2013 National Neurotrauma Society conference in Nashville, TN, held a special symposium as part of its annual meeting entitled, "High Throughput Technologies". Presenters in this session included Dr. Barbara Grimpe from the Heinrich Heine University, Düsseldorf, Germany ("Knowledge Da 
Conclusion
There is clearly a major impediment to achieving advancement from "bench to bedside" in both the SCI community, and beyond. Efforts to rectify the situation will require perhaps Herculean efforts on numerous fronts -from researchers, to reviewers, to publishers, to leaders in the execution of clinical trials (Landis et al., 2012) . While these efforts are paramount and should go forth with gusto and full-scale cooperation from the scientific community, there is still some doubt as to whether the level of detail and compliance to standardization required for success will be possible. For example, although the data elements recommended by Lemmon and colleagues include animal model and strain used, Basso et al. (2006) showed a differential motor recovery response to SCI in inbred or genetically engineered mouse strains and cautioned that inherent genetic factors significantly impact motor recovery and must be fully considered to accurately interpret results. It is difficult to imagine that numerous individual strains of each experimental animal will be accounted for in experimental design and taken into consideration in each set of analyses. However, such caveats with standing, we should strive to come as close as possible to the goal of standardization, and to adhere to minimal information standards in SCI research, as suggested by Lemmon et al. in "Facilitating transparency in spinal cord injury studies using data standards and ontologies". Such compliances will likely take us miles closer to comprehending the complex biochemical interactions that are involved in regeneration failure.
